Home/Filings/4/0001787306-24-000118
4//SEC Filing

Matsuda Masaru 4

Accession 0001787306-24-000118

CIK 0001787306other

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 4:37 PM ET

Size

5.6 KB

Accession

0001787306-24-000118

Insider Transaction Report

Form 4
Period: 2024-08-02
Matsuda Masaru
See Remarks
Transactions
  • Sale

    Common Stock

    2024-08-02$9.02/sh5,220$47,064183,288 total
Footnotes (2)
  • [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units.
  • [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $8.74 to $9.26, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Issuer

Arcutis Biotherapeutics, Inc.

CIK 0001787306

Entity typeother

Related Parties

1
  • filerCIK 0001798679

Filing Metadata

Form type
4
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 4:37 PM ET
Size
5.6 KB